The improvement of access to and data about therapeutic neoantigen cancer vaccines.
Compassionate access vaccine program - provide personalized neoantigen peptide vaccines for patients with cancer. Design, manufacture and deliver personalized vaccines to the treating physician through fda compassionate access protocol by partnering with experts in all of the design, manufacture and regulatory requirements.